New Hampshire physician assistant guilty
of Insys opioid kickback scheme
Send a link to a friend
[December 19, 2018]
By Nate Raymond
(Reuters) - A former physician assistant in
New Hampshire was convicted on Tuesday of charges that he accepted
nearly $50,000 in kickbacks from Insys Therapeutics Inc <INSY.O> in
exchange for prescribing its addictive fentanyl spray.
A federal jury in Concord, New Hampshire, found Christopher Clough, 45,
guilty of all charges he faced in a case that stemmed from a years-long
investigation into the Arizona company's efforts to promote its opioid
medication Subsys.
Clough is scheduled to be sentenced on March 29. Patrick Richard,
Clough's lawyer, said he is evaluating his options, including an appeal.
The verdict came a month before six former Insys executives and managers
including John Kapoor, a onetime billionaire who was its founder and
chairman, face trial on charges that they conspired to bribe medical
practitioners to prescribe Subsys.

The under-the-tongue spray is meant only for treating pain in cancer
patients and contains fentanyl, an opioid 100 times stronger than
morphine.
Prosecutors in that case allege Kapoor and his co-defendants conspired
to bribe doctors and others like Clough by paying them fees to
participate in speaker programs ostensibly meant to educate medical
professionals about Subsys that were actually shams.
Federal prosecutors in Boston have said they plan to introduce evidence
about Clough at the trial of Kapoor, former Chief Executive Michael
Babich and their co-defendants. They have pleaded not guilty.
Prosecutors said Clough, who worked at a clinic called PainCare in
Somersworth, New Hampshire, accepted nearly $50,000 from Insys to act as
a speaker while prescribing Subsys to mostly non-cancer patients.
[to top of second column]
|

Christopher Clough, a former physician assistant, arrives at the
federal courthouse in Concord, New Hampshire, U.S., December 12,
2018. REUTERS/Nate Raymond/File Photo

Witnesses at Clough's trial included two ex-members of Insys' sales
staff, Jeffrey Pearlman and Natalie Babich, who previously pleaded
guilty to conspiring to pay kickbacks and agreed to cooperate with
prosecutors.
Babich, a former sales representative who is now married to Michael
Babich, testified Clough frequently got paid for being a speaker at
dinners with her with no other attendees.
Pearlman, a former district sales manager, testified that Insys used
speaker fees to get doctors "more and more hooked on the company."
Clough's lawyers contended that he had no idea Insys was trying to
bribe medical practitioners like himself and that he prescribed
Subsys because he thought it would help his patients.
In August, Insys said it had agreed to settle a related U.S. Justice
Department probe for at least $150 million. It resolved a probe by
New Hampshire's attorney general focused on payments to Clough for
$3.4 million in 2017.
(Reporting by Nate Raymond in Boston, Editing by Alexia Garamfalvi
and Bill Berkrot)
[© 2018 Thomson Reuters. All rights
reserved.]
Copyright 2018 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
 |